Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

LinkMed’s portfolio company Likvor has received its first order for the Likvor CELDA™ system from a customer outside Sweden. The order comes from Aalborg Hospital which is the largest hospital in the North Denmark Region.

8 Mar 2010

Urinary catheterization of men and women: NAFC releases new consumer educational resource

The National Association For Continence (NAFC) has released a new consumer educational resource, focusing on catheterization procedures and care in the United States. The Urinary Catheterization of Men and Women pamphlet is the newest addition to NAFC's library of educational materials available to consumers seeking knowledge of management and treatment options for medical problems related to incontinence. It is also helpful as an educational supplement to nurses giving instructions to patients regarding their self-care.

4 Mar 2010

Macroplastique effective for stress urinary incontinence in women

Uroplasty, Inc. highlighted results from a two-year, multicenter clinical study of Macroplastique that will be published in the April 2010 print edition of The Journal of Urology(R). The 24-month study evaluated the durability of Macroplastique for stress urinary incontinence in women with previously documented success at 12 months. Substantial, durable results were sustained during 2 years with 84% of patients maintaining significant improvement from their 12-month assessment. Additionally, 67% of the patients implanted with Macroplastique were dry at the 24-month follow-up visit.

4 Mar 2010

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Antares Pharma, Inc. announced today that it has completed enrollment in the double-blind portion of the Company’s Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA), is expected in the third quarter of this year.

2 Mar 2010

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results of the SUmiT Trial of its Urgent® PC Neuromodulation System that will be published in the April 2010 print edition of THE JOURNAL OF UROLOGY® and is now available on line.

1 Mar 2010

Study: Several types of treatment can provide relief for pelvic floor disorders

Pelvic health concerns in women are common -- yet how the issues impact sexuality and childbearing is not often discussed, according to Mayo Clinic Women’s HealthSource.

18 Feb 2010

Article features pelvic health problems, risk factors and treatment options for women

Pelvic health concerns in women are common -- yet how the issues impact sexuality and childbearing is not often discussed, according to Mayo Clinic Women's HealthSource.

12 Feb 2010

Big Ow awareness campaign

When it comes to symptoms of menopause like hot flashes, weight gain or trouble sleeping, chances are most women wouldn't hesitate to speak to their doctor. But there is another common - and equally distressing - effect of menopause that many women just keep to themselves. The Big Ow, also known as vaginal atrophy, will affect as many as two million Canadian women in the next 10 years - but most are too shy or embarrassed to talk about it, even with their doctor.

8 Feb 2010

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company’s methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient’s breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.

27 Jan 2010

Inadequate saliva and fluoride can contribute to tooth decay

Tooth enamel is tough, harder even than skeletal bone. But even with good dental hygiene, the enamel protecting teeth may show signs of decay in older adults. The January issue of Mayo Clinic Health Letter covers what to look out for and what to do to promote an enamel-friendly setting in the mouth. According to the newsletter, two significant contributors to tooth decay are too little saliva and inadequate fluoride.

18 Jan 2010

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

LinkMed’s portfolio company Likvor has received a new order for Likvor CELDA™ ,this time from Sahlgrenska University Hospital in Gothenburg. With Likvor CELDA™ the clinical will be able to dynamic measure the most important parameters concerning the patients’ cerebrospinal fluid including pressure and flow in a controlled and safe process.

9 Jan 2010

AUA updates clinical practice guideline on female stress urinary incontinence

A complete evaluation, including an assessment of post-void residual volume, is key when evaluating a female patient for surgery to treat stress urinary incontinence (SUI), according to a new clinical practice guideline released today by the American Urological Association (AUA).

8 Jan 2010

Despite economic downturn, Russia still represents a promising healthcare market

Despite uncertain economic environment, Russia still represents a promising healthcare market with strong potential for further growth.

5 Jan 2010

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.

31 Dec 2009

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

LinkMed’s portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset).

11 Dec 2009

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®.

10 Dec 2009

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

Urodynamix Technologies Ltd. today announces that its Board of Directors has initiated a process to review strategic alternatives including the sale of part of or all of the Company's assets.

10 Dec 2009

Lab grown muscle cells raise hope for gastric reflux and fecal incontinence

A new study shows that muscle cells grown in the lab can restore an intestine's ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat patients with conditions such as gastric reflux and fecal incontinence.

5 Dec 2009

Urodynamix Technologies announces the publication of AMA's 2010 Current Procedural Terminology

Urodynamix Technologies Ltd. today announced that the American Medical Association (AMA) has published its 2010 Current Procedural Terminology (CPT) codes with additions, changes and deletions of billing codes for all medical specialities including urology.

23 Nov 2009

Data from second positive pivotal study of PSD502 for treatment of PE presented

At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

20 Nov 2009

Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Urinary catheterization of men and women: NAFC releases new consumer educational resource

Macroplastique effective for stress urinary incontinence in women

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Uroplasty's Urgent PC Neuromodulation System SUmiT Trial demonstrates effectiveness of PTNS

Study: Several types of treatment can provide relief for pelvic floor disorders

Article features pelvic health problems, risk factors and treatment options for women

Big Ow awareness campaign

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Inadequate saliva and fluoride can contribute to tooth decay

LinkMed’s portfolio company Likvor receives new order for Likvor CELDA

AUA updates clinical practice guideline on female stress urinary incontinence

Despite economic downturn, Russia still represents a promising healthcare market

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

Lab grown muscle cells raise hope for gastric reflux and fecal incontinence

Urodynamix Technologies announces the publication of AMA's 2010 Current Procedural Terminology

Data from second positive pivotal study of PSD502 for treatment of PE presented

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Urinary Incontinence News and Research

Latest Urinary Incontinence News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in